JPRN-UMIN000026228已完成未知
One-year Efficacy of Adjunctive Use of Ripasudil, a Rho-Kinase Inhibitor, in Patients with Glaucoma Inadequately Controlled under Maximum Medical Therapy - One-year efficacy of Ripasudil
Department of Ophthalmology and Micro-technology, Yokohama City University School of Medicine, Yokohama, Japan0 个研究点目标入组 50 人开始时间: 2017年2月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The exclusion criteria were as follows: presence of secondary, steroid-related, or traumatic glaucoma, and narrow angles that are defined as grade 2 or less according to the Shaffer classification, as assessed using gonioscopy. We also excluded patients who had undergone ocular surgeries, including cataract surgery within the previous year; retinal laser treatment, selective laser trabeculoplasty, glaucoma surgery, or Nd:YAG laser posterior capsulotomy within the previous 90 days; and eyelid surgery within the previous 120 days. Patients with a corrected visual acuity worse than 20/200 in either eye or with severe visual field defects were also excluded.
研究者
相似试验
尚未招募
不适用
To check efficacy of ripasudil in management of primary open angle glaucomaCTRI/2021/05/033754Dr Sowparnika A B
招募中
不适用
Ripasudil-brimonidine fixed-dose combination Observational study to Confirm the safety and efficacy of rho Kinase inhibitor and alpha2 adrenergic receptor agonist for long-term use in Japanese patients with glaucomaglaucoma, ocular hypertensionJPRN-UMIN000050123Japan society for Patient Reported Outcome5,000
尚未招募
不适用
se of Anti glaucoma eyedrop Ripasudil for treatment of corneal edema caused by cataract surgeryCTRI/2022/03/041064Office of Director General Armed Forces Medical Services
已完成
3 期
A clinical trial to study the beneficial effects of the drug Rupatadine in Low Back PaiCTRI/2019/06/019845SRM Institute of Science and Technology
已完成
不适用
Riluzol effect on treatment of drug resistant obsessive obsessive compulsive disorderObsessive-compulsive disorder.Obsessive-compulsive disorderIRCT20151103024853N5Deputy of research and technology developement32